A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty.

Slides:

Advertisements

Similar presentations

© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.

Advertisements

FRAILTY AND THE PREOPERATIVE ASSESSMENT Thomas Robinson, MD Associate Professor, Surgery University of Colorado August 5th, 2009 THE AMERICAN GERIATRICS.

Congenital Heart Disease: Outcome in Patients with Single Ventricle

Hospitalizations for Severe Sepsis Among Elderly Medicare Beneficiaries William Buczko, Ph.D. Research Analyst Centers for Medicare & Medicaid Services.

Advances In LVAD Patient Management

What have we learned? What is next? Panel B: Functional Capacity, Quality of Life and Outcomes H.Functional Capacity I.Neurocognitive Assessment J.Quality.

Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.

Periportal Fibrosis Without Cirrhosis Does Not Affect Outcomes Following Continuous Flow Ventricular Assist Device Implantation Jonathon E. Sargent, BS,

Indication and contra-indications for cardiac catheterization

Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana Advanced Heart Failure, Transplant, & Mechanical.

Mechanical Circulatory Support in Special Populations Renzo Y. Loyaga-Rendon MD.,PhD.. Assistant Professor Advanced Heart Failure Section University of.

All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.

Disability, Frailty and Co-Morbidity L. Fried et al. Gero 302 Jan 2012.

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Concomitant Aortic Valve Repair in Patients Undergoing Continuous-flow Left Ventricular Assist Device Placement: A 10-year Experience and Clinical Implications.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk Assessment and Comparative Effectiveness of.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Tolerability and efficacy of carvedilol in patients.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.

Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.

Acute Liver Failure Anand Annamalai.

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Description: The goal of the trial was to assess.

Assist Devices for the Treatment of Cardiogenic Shock

Role of ECMO in Acute Cardiogenic Shock

Giuseppe Tarantini MD, PhD

Dr M B Connellan Stellenbosch University

From: Independent Predictors and Outcomes of Unanticipated Early Postoperative Tracheal Intubation after Nonemergent, Noncardiac Surgery Anesthes. 2011;115(1):44-53.

EFFECTS OF INTRAPULMONARY PERCUSSIVE VENTILATION AS COMPLEMENTARY TECHNIQUE IN NONINVASIVE MECHANICAL VENTILATION DURING COPD EXACERBATIONS.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Objectives Describe the cardiovascular monitoring techniques used in the care of critically ill patients and how to interpret the results of hemodynamic.

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients James K. Kirklin, MD, David C. Naftel,

The Relationship Between Mental and Physical Health

Left Ventricular Dysfunction With Pulmonary Hypertension

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Phase I Clinical Trial of Autologous Stem Cell–Sheet Transplantation Therapy for Treating Cardiomyopathy by Shigeru Miyagawa, Keitaro Domae, Yasushi Yoshikawa,

Iatrogenic Adverse Events in the Coronary Care Unit

Effect of intervention on diastolic function.

Recently Diagnosed vs Chronic HF Associated with Better Outcomes

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

Optimal Pacing for Right Ventricular and Biventricular Devices

by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M

More Than Survival: Futility

BENEFIT Trial design: Patients with positive serologic tests for T. Cruzi and cardiomyopathy were randomized to benznidazole 300 mg daily for days.

EMPA-REG OUTCOME: The Cardiologist's Point of View

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure Jacques D. Donzé, MD, MSc, Patrick.

CIBIS II: Cardiac Insufficiency Bisoprolol Study II

Monthly Journal article review: Vimmi Kang PGY 2

Section III: Neurohormonal strategies in heart failure

Division of Cardiovascular Diseases No relevant author disclosures

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Guidelines for the Older Adult With CKD

Initial Clinical Experience With the Symphony Heart Assist System

Left Ventricular Assist Device Destination Therapy Versus Extended Criteria Cardiac Transplant Mani A. Daneshmand, MD, Keshava Rajagopal, MD, PhD, Brian.

Connie W. Tsao et al. JCHF 2016;4:

Neal A. Chatterjee et al. JCHF 2014;2:

Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.

Jerry D. Estep et al. JCHF 2013;1:

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

Frailty and Its Effect on the 4 M’s

Connie W. Tsao et al. JCHF 2016;4:

Algorithm for haemodynamic evaluation in the elderly.

Time to first event analysis revealed a significant difference in estimated event-free (death or hospitalisation) survival between patients with left ventricular.

Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: Are women different from men?

Distribution of NEWS in the community by service

Survival of subjects listed for heart transplantation with different spirometric ventilatory patterns. Survival of subjects listed for heart transplantation.

Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.

Presentation transcript:

A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty. A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty. Frailty is a heightened state of vulnerability in the face of stress and results from the accumulation of multimorbidity, aging, and disability. In advanced heart failure with reduced left ventricular ejection fraction, a patient's heart failure contributes significantly to the frailty syndrome and is potentially reversible with LVAD (LVAD-responsive frailty). However, many patients with advanced heart failure may be frail due to illness unrelated to heart failure severity, which is not treatable with LVAD (LVAD-independent frailty). Heart failure-related and nonheart failure-related factors combine to adversely affect health outcomes through several common effectors of frailty. LVAD indicates left ventricular assist device; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; COPD, chronic obstructive pulmonary disease; LOS, length of stay; ICU, intensive care unit; ADLs, activities of daily living. B, Patients undergoing DT LVAD with similar total baseline frailty but differing underlying causes of frailty. Patient A, with primarily LVAD-responsive frailty (ie, mostly heart failure-related illness), is likely to experience a good outcome if he or she survives the early postoperative period. Conversely, Patient C, with primarily LVAD-independent frailty (ie, mostly noncardiac-related illness), is at greater risk of death, complications (eg, stroke, gastrointestinal bleed, or chronic hemolytic anemia) and/or persistently poor functional status after LVAD placement. Of note, most DT patients are more like Patient B with evidence of significant LV dysfunction warranting LVAD but also significant comorbidity and/or advanced age disqualifying them from transplantation. DT indicates destination therapy; LVAD, left ventricular assist device. Kelsey M. Flint et al. Circ Heart Fail. 2012;5:286-293 Copyright © American Heart Association, Inc. All rights reserved.